Basic Information
| LncRNA/CircRNA Name | HANR |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | colorectal cancer |
| ICD-0-3 | C19.9 |
| Methods | qRT-PCR |
| Sample | CRC tissues |
| Expression Pattern | up-regulated |
| Function Description | elevated HANR expression was positively correlated with more advanced and aggressive CRC features, such as a larger tumor size (P=.003), increased invasion depth (P=.012), and more advanced TNM stage (P=.011).lncRNA HANR is a promising prognostic indicator in CRC patients. |
| Pubmed ID | 32049807 |
| Year | 2020 |
| Title | Long non-coding RNA HANR as a biomarker for the diagnosis and prognosis of colorectal cancer |
External Links
| Links for HANR | GenBank HGNC NONCODE |
| Links for colorectal cancer | OMIM COSMIC |